There are environmental determinants and genetic susceptibility to coronary heart disease (CHD); however, identifying factors that modify genetic risk has been difficult. Evidence suggests that a common polymorphism in the hepatic lipase gene (LIPC-480C>T) may be related to susceptibility to CHD and that physical activity is a behavioral factor associated with CHD. This population-based prospective study in the San Luis Valley of Colorado investigated the role of the LIPC-480C>T polymorphism in predicting clinical CHD and the modifying effect of physical activity. Hispanics and non-Hispanic Whites (n = 966) were followed for 14 years (1984)(1985)(1986)(1987)(1988)(1989)(1990)(1991)(1992)(1993)(1994)(1995)(1996)(1997)(1998); 91 CHD events occurred. The LIPC-480 TT genotype predicted an increase in CHD in both ethnic groups, and physical activity altered this relation. In the full cohort, the rate of CHD was significantly elevated among subjects with the high-risk genotype and normal levels of physical activity (hazard ratio = 2.58, 95% confidence interval: 1.39, 4.77) but was not elevated among those with the high-risk genotype who participated in vigorous physical activity (hazard ratio = 0.52, 95% confidence interval: 0.12, 2.19) (reference group: LIPC-480 CC/CT, normal physical activity). Thus, in this prospective cohort study, the LIPC-480 TT genotype increased susceptibility to CHD only in those subjects with normal levels of physical activity, not in those with the high-risk genotype who were vigorously active. cohort studies; coronary disease; genetic predisposition to disease; polymorphism (genetics); risk factors Abbreviations: CHD, coronary heart disease; HDL, high density lipoprotein; LDL, low density lipoprotein; SD, standard deviation.
480C>T) is responsible for differential effects of physical activity on HDL cholesterol levels and modifies the relation between obesity and hepatic lipase (18, 19) .
Recent studies have revealed the importance of the LIPC-480C>T polymorphism as a susceptibility marker for increased CHD, despite the relation between the LIPC-480 T allele and higher HDL cholesterol levels. The LIPC-480 T allele is associated with endothelial dysfunction (20) , coronary artery calcification (21) , the extent of coronary stenosis in patients with CHD (22) , and prevalent CHD case-control status in men (23, 24) . Given the apparent relation with CHD, the interaction between the LIPC-480C>T polymorphism and physical activity, and the variable response of hepatic lipase to exercise, the current investigation was designed to examine the impact of the LIPC-480C>T polymorphism and physical activity on clinical CHD in a population-based prospective study.
MATERIALS AND METHODS

Study population
The study population we analyzed consisted of subjects without diabetes or impaired glucose tolerance at baseline from the San Luis Valley Diabetes Study, a population-based prospective cohort study of diabetes and its consequences in a biethnic population of Hispanics and non-Hispanic Whites (25) . These study subjects were ascertained by using a geographic two-stage sampling procedure within the twocounty area of the San Luis Valley of rural southern Colorado. All residential structures were identified by using maps, directories, aerial photography, and utility customer service records. A 21 percent random sample of occupied structures was selected and its residents contacted to identify all persons living in the household and their demographic characteristics; 96.6 percent of eligible households completed the interview. The second stage of recruitment consisted of a random sample of subjects aged 20-74 years at the baseline visit (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) who agreed to undergo a fasting, 2-hour, 75-g oral glucose tolerance test (68.4 percent of those eligible). Diabetes status was based on the 1995 World Health Organization criteria or subjects using oral hypoglycemic agents or insulin. All participants completed a clinic examination that included anthropomorphic measures, blood draw for laboratory measures, and diet, physical activity, and medical history questionnaires. Hypertension was defined as current use of antihypertensive medications or a diastolic blood pressure of ≥90 mmHg or a systolic blood pressure of ≥140 mmHg from the mean blood pressure of the second and third measurements of the fifth-phase tone auscultated from the right arm by using a mercury sphygmomanometer after the subject rested in the supine position for 5 minutes. All procedures were approved by the Colorado Multiple Institutional Review Board, and all subjects provided signed informed consent.
Morbidity and mortality follow-up
Vital status and CHD morbidity were determined subsequent to the baseline visit through 1998 by yearly telephone interviews, obituary monitoring, or death certificate searches of the Colorado State Department of Health. Medical records or autopsy or coroner's reports were obtained for those for whom events occurred. Cause of death was determined by a three-member committee and was coded by using International Classification of Diseases, Ninth Revision, criteria. CHD included codes 410-414.9 (acute, subacute, and chronic ischemic heart disease). Nonfatal CHD was defined as a reported heart attack or an electrocardiogram major Qwave abnormality (Minnesota code 1.1-1.2). This rural population is relatively stable, with follow-up status determined for 98 percent of all participants.
Laboratory methods
Plasma was collected after a 12-hour fast. Total cholesterol, HDL cholesterol, and triglycerides were determined by enzymatic methods, and LDL cholesterol was determined by the Friedewald equation if triglyceride levels were less than 400 mg/dl. LIPC-480 genotypes were determined by digestion of the polymerase chain reaction-amplified promoter sequences with NlaIII (26) . Nomenclature of the LIPC promoter polymorphism (i.e., LIPC-480) is based on the sequence published by Cai et al. (27) and represents the same position as the LIPC-514 polymorphism.
Physical activity assessment
Study subjects were interviewed in English or Spanish regarding participation in vigorous activity at both work and during leisure time (refer to Mayer-Davis et al. (28) for details). Vigorous activity included any activity that the study participant considered strenuous or caused fatigue, increased heart rate, or sweating. Study subjects were ranked on the basis of the frequency and duration of vigorous activity as participating in no vigorous physical activity (sedentary), vigorous activity less than three times a week for at least 20 minutes (moderate), or vigorous activity three or more times a week for at least 20 minutes (vigorous). Analyses indicated that sedentary and moderate physical activity had similar relations with CHD; therefore, these two categories were combined in subsequent analyses.
Statistical methods
Analysis of variance was used for simple comparisons (Wilcoxon's or Kruskal-Wallis rank tests if the data were not normally distributed). In this paper, results are presented as mean (standard deviation (SD)). Differences in lipids by LIPC-480 genotype were adjusted for age, sex, and ethnicity. To compare genotype distributions, we used the χ 2 test and Mantel-Haenszel stratified analysis (stratified by ethnicity).
Cox proportional hazards modeling was used to test the a priori hypothesis of a relation between the LIPC-480C>T polymorphism and CHD events (age to CHD, fatal or nonfatal, as the dependent variable) and an interaction with physical activity after accounting for other potential predictive variables. To date, no other candidate genes have been examined as predictors of CHD in this cohort. Interactions with the LIPC-480 genotype were included based on potential physiologic relevance (i.e., physical activity, hypertension, diabetes) as well as ethnicity, with a significance level of p = 0.10 to be included in the model. The strength of the association was expressed as a hazard ratio. A backwards stepwise method was used to determine independent predictive variables. Analyses were performed by using the Statistical Analysis System (SAS, version 8.1; SAS Institute, Inc., Cary, North Carolina).
Variables that did not remain in the final model included smoking, LDL cholesterol, triglyceride (log transformed), waist circumference, body mass index, and lipid-lowering medications (gemfibrozil, n = 7; cholestryramine, n = 3; and lovastatin, n = 5). Smoking was analyzed as yes/no and as current/ex/never smokers. Although there was an increase in the proportions of cases among the ex-smokers and current smokers (8 percent among never smokers, 13 percent among ex-smokers, and 9 percent among current smokers), these differences were not statistically significant. This finding is consistent with early reports from this cohort (29, 30) . LDL cholesterol did not remain in the model that included total cholesterol. When total cholesterol was removed from the model, LDL cholesterol was a significant predictor of CHD (p < 0.01). Triglyceride is an independent predictor of CHD in some, but not all, cohorts (31) , and it may be complicated by a nonlinear relation between triglyceride and CHD (32) .
The role of ethnicity in the relation between the LIPC-480 polymorphism and CHD was considered in the following ways. First, the proportion of CHD cases with each genotype was not different between ethnic groups (figure 1). Second, Kaplan-Meier survival curves were stratified by ethnicity, and LIPC-480 genotypes showed a similar CHD-free survival in both Hispanics and non-Hispanic Whites. Third, ethnicity was forced to remain as a confounding variable in the Cox proportional hazards model, and the effect of the LIPC-480 genotype on CHD was independent of ethnicity. Fourth, an interaction between ethnicity and the LIPC-480 genotype was tested; this interaction term was not significant (p = 0.97) and did not alter the relation between LIPC-480 genotype and CHD. Finally, multivariate analyses were also performed for Hispanics and non-Hispanic Whites sepa- 
RESULTS
The study population (n = 966) consisted of 397 Hispanics and 569 non-Hispanic Whites (table 1) The cohort was followed for 14 years, and 91 CHD events were recorded. Those for whom CHD events occurred were older (59.3 (SD, 9.4) years vs. 51.1 (SD, 11.9) years, p < 0.001) and more likely to be male (76.9 percent vs. 45.7 percent, p < 0.001) (table 2). Those with CHD had a worse lipid profile, with significantly higher triglyceride, total and LDL cholesterol, and lower HDL cholesterol levels. Body mass index, waist-to-hip ratio, and blood pressure all were significantly higher in those who had CHD events. No difference in ethnicity was found between those with or without CHD. There was a significant difference in the LIPC-480 genotype distribution between CHD cases and those without CHD, with an excess of LIPC-480 TT homozygous subjects among those with CHD compared with those without CHD (p = 0.04).
No significant differences were found in HDL cholesterol (p = 0.32), HDL 2 cholesterol (p = 0.55), or HDL 3 cholesterol (p = 0.17) by LIPC-480 genotype. We found a modest difference in plasma triglyceride levels between LIPC-480 genotypes (152 (SD, 73.0) mg/dl, 151 (SD, 107.0) mg/dl, and 138 (SD, 74.9) mg/dl for LIPC-480 TT, CT, and CC genotypes, respectively; p = 0.03). figure  3 ). Vigorous physical activity did not significantly alter the risk of CHD for subjects with the LIPC-480 CC or CT genotype (p = 0.62); however, a reduced risk due to vigorous physical activity was found for subjects with the LIPC-480 TT genotype (p = 0.03 comparing vigorous physical activity with sedentary or moderate physical activity among LIPC-480 TT subjects). Subjects with this high-risk genotype who participated in vigorous physical activity did not have an increase in CHD (hazard ratio = 0.52, 95 percent confidence interval: 0.12, 2.19), while those with the high-risk genotype who did not participate in vigorous physical activity did have a significant increase in CHD (hazard ratio = 2.58, 95 percent confidence interval: 1.39, 4.77) (reference group for both comparisons: LIPC-480 CC/CT without vigorous activity).
DISCUSSION
This study showed that the LIPC-480 TT genotype predicted an increase in CHD for subjects who participated in normal levels of physical activity, but this increase was not found for subjects with the high-risk genotype who took part in vigorous physical activity. Those subjects who carried the LIPC-480 TT genotype and participated in activ- ities they considered strenuous-those that caused fatigue, increased heart rate, or sweating for 20 minutes three times a week-did not appear to have the increase in CHD associated with this high-risk genotype. The mechanism by which the LIPC-480C>T polymorphism promotes CHD has yet to be elucidated. In this study, the effect of the LIPC-480 TT genotype on CHD was independent of HDL cholesterol. Others have shown a modest increase in HDL cholesterol associated with the LIPC-480 T allele (23, 33, 34) , which was not observed in the current study. One potential mechanism may relate to the role that hepatic lipase plays in remnant lipoprotein metabolism (35, 36) . Variations in the hepatic lipase gene are associated with higher levels of intermediate density lipoprotein (14) , the lipid content of intermediate density lipoprotein (37) , and higher LpCIII:B particles (34) . These atherogenic lipoproteins (38, 39) were not measured in the current study and may account for the observed relation between the LIPC-480 polymorphism and CHD.
Accumulating evidence now seems to support a role for the LIPC-480 T allele and increased susceptibility to CHD. The LIPC-480 T allele is also associated with a decrease in coronary flow reserve (20) , the presence (21) and extent (21, 22) of subclinical CHD, and prevalent case-control status in some (23, 24) , but not all (37, 40) , studies. To our knowledge, no studies have reported a protective effect of the LIPC-480 T allele despite its impact on HDL cholesterol levels, and no studies have investigated an interaction between LIPC-480 genotypes and physical activity on risk of CHD.
It was intriguing to note the effect of physical activity for subjects with the LIPC-480 TT genotype that has been associated with decreased coronary flow reserve (20) , a measure of endothelial dysfunction. Exercise has a favorable effect on coronary flow reserve (41) , perhaps by decreasing triglyceride-rich remnant lipoproteins that alter endothelial function (42) . The effect of vigorous physical activity on the risk of CHD associated with the LIPC-480C>T polymorphism may be due to the exercise-induced decrease in remnant lipoproteins and a subsequent increase in coronary flow reserve in subjects with a genetic susceptibility to these abnormalities. Confirmation of this hypothesis will require further study.
Of particular importance is that the impact of the high-risk genotype appears to be altered by levels of physical activity. This interaction of gene and environment draws particular attention to the need to investigate the efficacy of targeted intervention studies that lead to increases in physical activity. Vigorous activity of 20 minutes or more three or more times a week limits the adverse effect of the LIPC-480 high-risk genotype on CHD. In this study, physical activity was assessed by using a structured interview. This method has been validated against other measures of physical activity; however, there undoubtedly is misclassification in this measure. It is most likely that this misclassification is nondifferential with respect to both LIPC-480 genotype and subsequent CHD; thus, it is expected that the true impact of vigorous physical activity may be greater than observed in this study. Given that the LIPC-480C>T polymorphism is relatively common (allele frequency of 0.19 in non-Hispanic Whites, 0.47 in Hispanics, and 0.45-0.54 in AfricanAmericans (33, 43) ) stresses the potential benefit of a successful physical activity intervention targeted at subjects who carry the high-risk genotype. In fact, one would anticipate an even greater impact of increased physical activity mediated through mechanisms other than the hepatic lipase gene, such as weight loss and cardiorespiratory fitness. The benefits of changing physical activity levels in this high-risk group remains to be determined, however.
In conclusion, in this population-based prospective study, the hepatic lipase promoter polymorphism (LIPC-480 TT genotype) predicted a greater than twofold increase in CHD. The increase in CHD associated with this high-risk genotype was seen only for subjects who participated in normal levels of physical activity. Subjects who carried the high-risk genotype and who participated in vigorous physical activity (20 minutes three times a week) did not exhibit an increase in CHD. These data support a role for gene-environment interaction in the susceptibility to coronary disease and may provide an important impetus for increasing levels of physical activity to prevent CHD in high-risk populations. 
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